4D Molecular Therapeutics Inc

XNAS: FDMT

Download real time

3.92 0.17 (4.53%)

New 52W Low today

1.3M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

181.5

Market Cap

Below industry Median

0.1

Beta 1Year

Very Low volatility

4D Molecular Therapeutics Inc - FDMT - stock price prediction, stock price target, analyst ratings from 12 analysts

4D Molecular Therapeutics Inc has a share price target of US$ 34, revenue growth forecast of 12025.0%, and profit growth estimate of -23.1% for FY25, based on top 12 analyst calls.

Forecaster Screeners